A narrative review of immune-mediated adverse events in clinical trials of CpG oligonucleotide toll-like receptor 9 agonists. Janssen RS, Coffman RL. Vaccine 2026;79:128437.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Janssen RS, Coffman RL. A narrative review of immune-mediated adverse events in clinical trials of CpG oligonucleotide toll-like receptor 9 agonists. Vaccine 2026;79:128437.
PMID: 41819640